Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein

被引:34
作者
Liu, HY [1 ]
Sperelakis, N [1 ]
机构
[1] UNIV CINCINNATI, COLL MED, DEPT MOL & CELLULAR PHYSIOL, CINCINNATI, OH 45267 USA
关键词
tyrosine kinase activity; genistein inhibition; vascular smooth muscle; single Ca2+ channel activity; single-channel recording;
D O I
10.1139/cjpp-75-9-1063
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In a previous study, we demonstrated that extracellular application of the tyrosine kinase inhibitor genistein produced a dose-dependent inhibition of the macroscopic slow (L-type) Ca2+ currents of vascular smooth muscle (VSM) cells, and that daidzein, an inactive analog of genistein, had no such effect. These results suggested that the L-type Ca2+ channels in VSM cells may be modulated by endogenous tyrosine kinase activity. To confirm and extend those findings, the effect of genistein on the activity of single Ca2+ channels was examined in freshly isolated single VSM cells from rat portal vein, using the cell-attached patch-clamp technique. The pipette solution contained 90 mM Ba2+ as charge carrier and 0.5 mu M Bay K 8644 (to enhance basal activity of the channels), and the bath contained 140 mM KCl to ''zero'' the resting membrane potential. Depolarizing pulses to 0 mV, from a holding potential of -80 mV, elicited inward unitary currents that were blocked by 1 mu M nifedipine (n = 6). The slope conductance of the unitary Ca2+ currents gave a value of 21.5 +/- 0.4 pS (n = 9) for the Ca2+ channels. Bath application of genistein (50 mu M) did not change the unit amplitude and slope conductance: the conductance in the presence of genistein was 22.2 +/- 0.5 pS (n = 6). However, compared with controls, the activity of single Ca2+ channels was significantly inhibited by genistein in a dose-dependent fashion. The ensemble-averaged currents were decreased by 48.4 +/- 11.2% with 50 mu M genistein; 100 mu M genistein inhibited the Ca2+ currents by 76.8 +/- 11.8%. The open probability (NP0) was decreased by 50 mu M genistein from 0.24 +/- 0.09 to 0.11 +/- 0.07. Single-channel kinetic analysis showed that genistein decreased the mean open time and prolonged the mean closed time. The inhibitory effect of genistein on the Ca2+ channnel activity occurred within 3 min, and it could be reversed by washout within 3-5 min. Daidzein, in concentrations up to 300 mu M, produced no change in the activity of the single Ca2+ channels. These results demonstrate that genistein inhibits the activity of the L-type Ca2+ channels in VSM cells, suggesting that the availability of the channels for voltage activation may be maintained through tonic tyrosine kinase phosphorylation.
引用
收藏
页码:1063 / 1068
页数:6
相关论文
共 29 条
[1]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[2]   CELLULAR ONCOGENES AND RETROVIRUSES [J].
BISHOP, JM .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :301-354
[3]   PROTEIN-KINASE ACTIVITY ASSOCIATED WITH AVIAN-SARCOMA VIRUS SRC GENE PRODUCT [J].
COLLETT, MS ;
ERIKSON, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (04) :2021-2024
[4]  
COOPER JA, 1983, CURR TOP MICROBIOL, V107, P125
[5]   TYROSINE KINASE INHIBITORS SUPPRESS AGONIST-INDUCED CONTRACTION IN SMOOTH-MUSCLE [J].
DISALVO, J ;
STEUSLOFF, A ;
SEMENCHUK, L ;
SATOH, S ;
KOLQUIST, K ;
PFITZER, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (03) :968-974
[6]   STIMULATION OF TYROSINE-SPECIFIC PHOSPHORYLATION BY PLATELET-DERIVED GROWTH-FACTOR [J].
EK, B ;
WESTERMARK, B ;
WASTESON, A ;
HELDIN, CH .
NATURE, 1982, 295 (5848) :419-420
[7]   SIGNALING BY RECEPTOR TYROSINE KINASES [J].
FANTL, WJ ;
JOHNSON, DE ;
WILLIAMS, LT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :453-481
[8]  
HAMILL OP, 1981, PFLUEGERS ARCH, V391, P83
[9]   THE PROTEIN-KINASE FAMILY - CONSERVED FEATURES AND DEDUCED PHYLOGENY OF THE CATALYTIC DOMAINS [J].
HANKS, SK ;
QUINN, AM ;
HUNTER, T .
SCIENCE, 1988, 241 (4861) :42-52
[10]   TYROSINE KINASE PATHWAYS AND THE REGULATION OF SMOOTH-MUSCLE CONTRACTILITY [J].
HOLLENBERG, MD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (04) :108-114